Tata Elxsi Offshore Development Centre Boosts Med Tech Innovation

Tata Elxsi and Terumo Corporation have launched the Terumo–Tata Elxsi Offshore Development Centre to strengthen global support for cardiac and vascular solutions. The new centre will drive faster product development, better engineering quality, and stronger regulatory compliance for Terumo’s med tech innovation across international markets.

The Terumo–Tata Elxsi Offshore Development Centre combines Tata Elxsi’s deep expertise in design, software engineering, verification, regulatory compliance, and localization. It also brings in AI, GenAI, and digital capabilities to help Terumo build patient?centric medical devices with improved cost efficiency and clearer product differentiation.

Also Read: How Digital Maturity is Powering Pharma's GMP Evolution

This collaboration sets up multidisciplinary teams focused on meeting the rising demand for advanced cardiac and vascular technologies. With Tata Elxsi’s engineering and regulatory support, Terumo can adapt products more quickly for regional needs while keeping up with industry standards and evolving healthcare requirements.

Fumihisa Hirose, president of Terumo’s Cardiac & Vascular Company, said, “This new Offshore Development Center strengthens our ability to innovate faster and deliver high?quality medical technologies across global markets. Tata Elxsi’s integrated design, engineering, and regulatory expertise will help us accelerate our global product roadmap while maintaining the highest standards of safety and compliance.”

Sreevatsa Sahasranaman, senior vice president and head of healthcare & life sciences at Tata Elxsi, added, “This Offshore Development Centre represents a comprehensive long?term partnership model with Terumo Corporation to bring Tata Elxsi’s multi?disciplinary, cross?functional and deep domain expertise to drive innovation and cost efficiencies across Terumo’s Cardiovascular portfolio.”